ACT-A2; ACTSA; ACTVS; Asma; GIG46; Cell growth-inhibiting gene 46 protein
TP53; LFS1; TRP53; Li-Fraumeni Syndrome; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
NT5E; NT5-E; E5NT; E5-NT; NTE; EN; ENT; 5'-Nucleotidase, Ecto
TXN; ADF; SASP; TRDX; TRX1; ATL-derived factor; Surface-associated sulphydryl protein
NGFB; Beta-NGF; HSAN5; NGF-B; Beta-Nerve Growth Factor
CD107B; INDO; Indoleamine-Pyrrole 2,3 Dioxygenase
MCAM; MUC18; Melanoma Cell Adhesion Molecule; Cell surface glycoprotein P1H12; Melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen
CD61; ITG-B3; GP3A; GP3-A; GpIIIa; Platelet Membrane Glycoprotein IIIa
PGA5; PG-A; Pepsinogen 5 Group I; Pepsinogen-5; Pepsin A-5
CD112; PVRL2; HVEB; PRR2; PVRR2; Herpesvirus Entry Mediator B; Herpes virus entry mediator B
ANX-A4; ANX4; PIG28; 35-beta calcimedin; Carbohydrate-binding protein p33/p41; Chromobindin-4; Endonexin I; Lipocortin IV; Placental anticoagulant protein II